Vantage BioTrials becomes Newest Member of Innovative Medicines Canada
February 10, 2016, Montréal, Canada – It is with pleasure that we announce the acceptance of Vantage BioTrials’ application for membership in the category of Life Sciences Associate Member by Innovative Medicines Canada (formerly Rx&D).
Through a model of advocacy and collaboration, Innovative Medicines Canada, and its members, work together with government and health stakeholders to improve the Canadian environment for innovation of and access to patented pharmaceuticals and ensure the development of policies that expand patient access to medicines and vaccines while rewarding innovation, research and investment.
Vantage BioTrials is looking forward to positively contributing to the projects and goals of Innovative Medicines Canada in the coming years.
About Vantage BioTrials Inc.
Vantage BioTrials Inc. is a leading Canadian Contract Research Organization (CRO) that provides Phase I-IV clinical trial management services to international biopharmaceutical, biotechnology, generic pharma and medical device companies within North America and Europe.
We are experts in implementing Risk-Based Management through the use of Quality by Design (QbD) methodologies, which helps accelerate the conduct of a study and reduces overall risk. As a result this ensures that your trial is performed correctly, the first time!
For more information about Vantage BioTrials’ services and capabilities, please visit vantagebiotrials.com.